Eris Lifesciences Limited (BOM:540596)

CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	228,746	192,990	114,719	77,801	93,615	82,147
Market Cap Growth	64.67%	68.23%	47.45%	-16.89%	13.96%	64.00%
Enterprise Value	255,644	221,970	121,268	80,085	92,600	80,183
Last Close Price	1679.10	1416.50	836.45	568.82	677.98	589.96
PE Ratio	59.18	54.85	29.26	20.36	23.05	23.13
PS Ratio	7.79	6.70	5.76	4.68	7.06	6.89
PB Ratio	6.99	5.90	3.56	3.50	4.91	5.21
P/TBV Ratio	-	-	-	-	8.10	10.28
P/FCF Ratio	-	21.21	32.15	-	36.39	23.50
P/OCF Ratio	-	18.12	23.60	26.67	24.75	21.89
EV/Sales Ratio	8.71	7.71	6.09	4.82	6.98	6.72
EV/EBITDA Ratio	23.64	22.09	18.30	15.23	19.18	18.82
EV/EBIT Ratio	34.76	31.59	24.53	18.99	21.81	20.69
EV/FCF Ratio	-	24.39	33.98	-	36.00	22.94
Debt / Equity Ratio	0.76	0.76	0.86	0.40	0.05	0.01
Debt / EBITDA Ratio	2.29	2.44	4.13	1.66	0.19	0.04
Debt / FCF Ratio	-	2.72	7.79	-	0.36	0.05
Asset Turnover	-	0.41	0.37	0.56	0.65	0.70
Inventory Turnover	-	2.80	2.47	2.90	2.49	2.95
Quick Ratio	-	0.56	0.75	1.22	1.99	1.78
Current Ratio	-	0.89	0.91	1.73	3.14	2.80
Return on Equity (ROE)	-	11.54%	14.59%	18.12%	23.29%	24.72%
Return on Assets (ROA)	-	6.24%	5.77%	8.87%	12.92%	14.31%
Return on Capital (ROIC)	7.81%	7.47%	6.78%	10.31%	14.76%	16.70%
Return on Capital Employed (ROCE)	-	12.40%	11.00%	13.10%	20.50%	23.20%
Earnings Yield	1.69%	1.82%	3.42%	4.91%	4.34%	4.32%
FCF Yield	-	4.71%	3.11%	-7.07%	2.75%	4.26%
Dividend Yield	0.43%	0.52%	-	1.29%	0.89%	0.93%
Payout Ratio	-	28.44%	-	26.14%	20.10%	21.03%
Buyback Yield / Dilution	-0.05%	-0.09%	-0.03%	-0.19%	-0.02%	1.03%
Total Shareholder Return	0.37%	0.43%	-0.03%	1.10%	0.86%	1.97%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.